Table 2 Clinical manifestations and laboratory results of Henoch–Schönlein purpura patients with and without gastrointestinal involvement
Variable | Total HSP patients (n = 69) | Gastrointestinal involvement (n = 40) | Non-gastrointestinal involvement (n = 29) | P value |
|---|---|---|---|---|
Age (years) | 6.85 ± 2.93 | 7.11 ± 2.67 | 6.48 ± 3.27 | 0.380 |
Male sex | 37 (53.6%) | 21 (52.5%) | 16 (55.2%) | 0.826 |
Duration of admission (days) | 5.41 ± 5.27 | 7.25 ± 6.05 | 2.79 ± 1.97 | 0.000* |
Joint symptoms | 35 (50.7%) | 16 (40.0%) | 19 (65.5%) | 0.036* |
Kidney involvement | 16 (23.2%) | 10 (25.0%) | 6 (20.7%) | 0.675 |
HSP clinical score | 1.99 ± 1.53 | 2.65 ± 1.59 | 1.07 ± 0.80 | 0.000* |
HSP recurrence | 23 (33.3%) | 15 (37.5%) | 8 (27.6%) | 0.389 |
Gastrointestinal symptom recurrence | 19 (27.5%) | 12 (30.0%) | 7 (24.1%) | 0.591 |
Positive stool occult blood result | 17 (24.6%) | 17 (42.5%) | 0 (0%) | 0.000* |
Fecal calprotectin (mg/kg) | 252.7 ± 343.8 | 379.9 ± 399.8 | 77.4 ± 97.6 | 0.000* |
WBC count (106/L) | 11,757 ± 5133 | 12,365 ± 6015 | 10,889 ± 3434 | 0.246 |
ANC (μL) | 7673 ± 4388 | 8476 ± 4716 | 6526 ± 3652 | 0.071 |
ESR (mm/h) | 23.74 ± 12.46 | 25.50 ± 12.62 | 21.04 ± 11.95 | 0.157 |
C-reactive protein (mg/L) | 5.87 ± 6.39 | 5.18 ± 5.65 | 6.87 ± 7.31 | 0.285 |
FDP (μg/mL) (n = 57) | 9.14 ± 9.16 | 11.08 ± 11.14 | 6.73 ± 5.07 | 0.064 |
D-dimer (μg/mL) (n = 57) | 2.34 ± 2.45 | 2.93 ± 2.89 | 1.61 ± 1.50 | 0.036* |